SCHEMBL4128122

SCHEMBL4128122

COc1ccc(C=C2SC(=S)N(Cc3ccc4c(c3)OCO4)C2=O)cc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.70
▸ KMT2A Q03164 10/20 0.70
▸ ATM Q13315 1/20 0.70
▸ PDE4B Q07343 2/20 0.65
▸ POLB P06746 6/20 0.60
▸ MAPK1 P28482 3/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ HSD17B3 P37058 1/20 0.56
▸ MAPT P10636 3/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ PSMD14 O00487 1/20 0.55
▸ GAA P10253 2/20 0.53
▸ HSP90AA1 P07900 1/20 0.53
▸ CASP3 P42574 1/20 0.53
▸ SENP8 Q96LD8 1/20 0.53
▸ SENP7 Q9BQF6 1/20 0.53
▸ SENP6 Q9GZR1 1/20 0.53
▸ PTPN2 P17706 1/20 0.52
▸ PTPN1 P18031 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128120 1.00 MEN1 (0.70) MEN1KMT2AATMPDE4BPOLB
SCHEMBL4133297 0.93 MEN1 (0.70) MEN1KMT2AATMPDE4BPOLB
SCHEMBL4133300 0.93 MEN1 (0.70) MEN1KMT2AATMPDE4BPOLB
SCHEMBL4130334 0.92 MAPK1 (0.60) MEN1KMT2AATMPDE4BPOLB
SCHEMBL4130332 0.92 MAPK1 (0.60) MEN1KMT2AATMPDE4BPOLB
SCHEMBL4126818 0.89 MEN1 (0.67) MEN1KMT2AATMPOLBMAPK1
SCHEMBL4126817 0.89 MEN1 (0.67) MEN1KMT2AATMPOLBMAPK1
SCHEMBL4138637 0.87 MAPK1 (0.72) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4138638 0.87 MAPK1 (0.72) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4132886 0.86 MAPT (0.64) MEN1KMT2APOLBMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed
WO-2008043733-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS LEK PHARMACEUTICAL D.D. (SI) 2008-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MEN1 2336/4885KMT2A 1459/4885ATM 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback